Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TARS

Tarsus Pharmaceuticals Inc

May 29 • 04:00PM ET

59.40

-0.14 -0.24 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN KRYS MIRM RYTM VKTX INCY AXSM MDGL KROS NBIX

| Held by: VTI IWM VXF IWO IBB VTWO SCHA PJP VHT IHE

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.13	Insider Own	6.18%	Shs Outstand	43.02M	Perf Week	-6.43%
Market Cap	2.56B	Forward P/E	19.58	EPS next Y	3.03	Insider Trans	-5.98%	Shs Float	40.37M	Perf Month	-2.09%
Enterprise Value	2.26B	PEG	-	EPS next Q	-0.22	Inst Own	104.45%	Short Float	12.15%	Perf Quarter	-21.35%
Income	-48.27M	P/S	4.78	EPS this Y	61.06%	Inst Trans	0.29%	Short Ratio	8.22	Perf Half Y	-24.70%
Sales	535.08M	P/B	7.32	EPS next Y	589.96%	ROA	-8.92%	Short Interest	4.91M	Perf YTD	-27.45%
Book/sh	8.11	P/C	6.57	EPS next 5Y	-	ROE	-13.96%	52W High	85.25 -30.32%	Perf Year	36.74%
Cash/sh	9.04	P/FCF	-	EPS past 3/5Y	14.26% -3.80%	ROIC	-11.03%	52W Low	38.51 54.25%	Perf 3Y	272.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	159.54% -	Gross Margin	93.48%	Volatility	3.40% 5.45%	Perf 5Y	78.27%
Dividend TTM	-	EV/Sales	4.22	EPS Y/Y TTM	58.46%	Oper. Margin	-9.50%	ATR (14)	3.00	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.71	Sales Y/Y TTM	128.99%	Profit Margin	-9.02%	RSI (14)	39.47	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	3.74	EPS Q/Q	74.59%	SMA20	-4.94%	Beta	0.49	Target Price	94.00
Payout	-	Debt/Eq	0.25	Sales Q/Q	106.87%	SMA50	-8.86%	Rel Volume	1.03	Prev Close	59.54
Employees	370	LT Debt/Eq	0.25	Earnings	May 06 AMC	SMA200	-12.58%	Avg Volume	596.93K	Price	59.40
IPO	Oct 16, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	60.03% 8.33%	Trades		Volume	615,695	Change	-0.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)